Effect of Everolimus with Low-Dose Tacrolimus on Development of New-Onset Diabetes After Transplantation and Allograft Function in Kidney Transplantation: A Multicenter, Open-Label, Randomized Trial

22 January 2021 : Original article

Hyung Duk Kim^1BEF, Ji-Yeun Chang^1CDE, Byung Ha Chung^1AB, Chan-Duck Kim^2B, Sang-Ho Lee^3B, Yeong Hoon Kim^4B, Chul Woo Yang^1ADG*

DOI: 10.12659/AOT.927984

Ann Transplant 2021; 26:e927984

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 2 Comparison of development of NODAT (ITT population).

	EVL group (n=38)	TAC group (n=39)	P-value*
	5 (13.16)	1 (2.56)	0.0819
	0 (0.00)	1 (2.56)	1.0000
	0 (0.00)	0 (0.00)	NA
Discrete variables are presented with n (%).

Back to the Article